Physician profile
William J Windham
NPI 1861832289
$6,849.22
in general payments reported to CMS, 2019-2025
34 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,660 · 2020: $458 · 2021: $527 · 2022: $2,771 · 2023: $523 · 2024: $550 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.93 |
| Education | $109.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,423.78 | 2019-2023 | Rezum Generator |
| Neotract INC. | $1,360.50 | 2019-2020 | |
| Teleflex LLC | $560.87 | 2021-2025 | Urolift, Barrigel |
| Edap Technomed INC | $378.00 | 2024 | |
| Dendreon Pharmaceuticals LLC | $276.01 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $257.85 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $222.34 | 2021-2023 | Lupron Depot |
| Janssen Biotech, INC. | $184.65 | 2019-2023 | Erleada |
| Myriad Genetic Laboratories, INC. | $135.77 | 2020-2024 | Prolaris |
| Medtronic, INC. | $102.19 | 2022-2023 | Interstim |
| Sumitomo Pharma America, INC. | $83.77 | 2025 | Orgovyx |
| Axonics, INC. | $65.88 | 2021-2023 | Axonics |
| Endo Pharmaceuticals INC. | $61.89 | 2021-2023 | Xiaflex, Aveed |
| Medtronic USA, INC. | $60.71 | 2020 | |
| Pfizer INC. | $59.81 | 2019-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $56.90 | 2023 | Aquabeam Robotic System |
| Cook Medical LLC | $50.25 | 2019 | |
| Coloplast Corp | $46.86 | 2020-2023 | Speedicath |
| Hollister Incorporated | $46.51 | 2022-2023 | Infyna Chic |
| Endo USA, INC. | $43.31 | 2025 | Xiaflex |
| Verity Pharmaceuticals INC. | $42.18 | 2023-2025 | Trelstar |
| Blue Earth Diagnostics | $35.69 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Merck Sharp & Dohme LLC | $34.59 | 2022-2025 | Lynparza |
| Urogen Pharma, INC. | $29.34 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.65 | 2023 | |
| Immunitybio, INC. | $28.32 | 2025 | |
| Novartis Pharmaceuticals Corporation | $24.28 | 2025 | |
| Pacira Therapeutics, INC. | $20.92 | 2020 | |
| Travere Therapeutics, INC. | $20.01 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $18.98 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.89 | 2025 | Adstiladrin |
| Photocure INC | $17.51 | 2021 | |
| Olympus America INC. | $16.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Windham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.